Patent · US Active

Anti-MN antibodies and methods of using same

US8168758B2 · kind B2 · utility

3Cited by
2References
29Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 12, 2006
Grant dateMay 1, 2012
Priority date
Expiry dateMar 20, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides antibodies having an antigenic binding site specifically directed against an MN protein, and methods for using such antibodies in treating and diagnosing an MN-related disorder.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.